FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Advisors Vote 9-8 for Hexvix

[ Price : $8.95]

FDAs Oncologic Drugs Advisory Committee recommends 9-8 that FDA approve Photocures Hexvix bladder cancer imaging drug.

Keryx Biopharmaceuticals Opens a Phase 3 Perifosine Trial

[ Price : $8.95]

Keryx Biopharmaceuticals opens a Phase 3 trial of perifosine in relapsed and refractory multiple myeloma patients.

FDA Clears Agendias MammaPrint for All Ages

[ Price : $8.95]

FDA clears an Agendia 510(k) for the MammaPrint breast cancer recurrence test that broadens its use to women of all ages.

FDA OKs Elanco sNADA for Swine Feed

[ Price : $8.95]

Federal Register Final rule: FDA approves an Elanco Animal Health sNADA for using two-way combination swine feeds formulated with ...

ICH Guidance on Safety of Biotechnology-Derived Pharmaceuticals

[ Price : $8.95]

Federal Register Notice: FDA releases an ICH draft guidance, Addendum to ICH S6: Preclinical Safety Evaluation of Biotechnology-De...

Drug Companies Cutting Sales Staffs

[ Price : $8.95]

Reuters reports that many drug companies in the U.S. and Europe are cutting the number of sales reps as doctors lose influence ove...

ICH Guidance on Capillary Electrophoresis

[ Price : $8.95]

Federal Register Notice: FDA releases an ICH draft guidance, Q4B Evaluation and Recommendation of Pharmacopeial Texts for Use in t...

ICH Guidance on Analytical Sieving General Chapter

[ Price : $8.95]

Federal Register Notice: FDA releases an ICH draft guidance, Q4B Evaluation and Recommendation of Pharmacopeial Texts for Use in t...

Panel to Discuss Non-Hodgkins Lymphoma NDA

[ Price : $8.95]

Federal Register Notice: FDAs Oncologic Drugs Advisory Committee will meet 2/10 to discuss Cell Therapeutics NDA for Pixuvri to tr...

Public Workshop on Clinical Trial Requirements

[ Price : $8.95]

Federal Register Notice: FDA Florida District and the Society of Clinical Research Associates will hold a public workshop 3/3-4/10...